TABLE OF CONTENTS
|  |  |  | Volume 31, Issue 29 (July 2012) |  | In this issue
Original Articles
Corrigendum
Also new
   AOP
| |  |  | | Advertisement |  | |  | | | Original Articles | Top |  | PAK1 is a breast cancer oncogene that coordinately activates MAPK and MET signalingY Shrestha, E J Schafer, J S Boehm, S R Thomas, F He, J Du, S Wang, J Barretina, B A Weir, J J Zhao, K Polyak, T R Golub, R Beroukhim and W C Hahn Oncogene 2012 31: 3397-3408; advance online publication, November 21, 2011; 10.1038/onc.2011.515 Abstract | Full Text |  |  |  | Downregulation of PRDX1 by promoter hypermethylation is frequent in 1p/19q-deleted oligodendroglial tumours and increases radio- and chemosensitivity of Hs683 glioma cells in vitroL M Dittmann, A Danner, J Gronych, M Wolter, K Stühler, M Grzendowski, N Becker, J Bageritz, V Goidts, G Toedt, J Felsberg, M C Sabel, S Barbus, G Reifenberger, P Lichter and B Tews Oncogene 2012 31: 3409-3418; advance online publication, December 12, 2011; 10.1038/onc.2011.513 Abstract | Full Text |  |  |  | Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patientsX Li, K F Cheung, X Ma, L Tian, J Zhao, M Y Y Go, B Shen, A S L Cheng, J Ying, Q Tao, J J Y Sung, H-f Kung and J Yu Oncogene 2012 31: 3419-3430; advance online publication, November 21, 2011; 10.1038/onc.2011.511 Abstract | Full Text |  |  |  | Synergistic antitumor activity of lapatinib and retinoids on a novel subtype of breast cancer with coamplification of ERBB2 and RARAG Paroni, M Fratelli, G Gardini, C Bassano, M Flora, A Zanetti, V Guarnaccia, P Ubezio, F Centritto, M Terao and E Garattini Oncogene 2012 31: 3431-3443; advance online publication, November 7, 2011; 10.1038/onc.2011.506 Abstract | Full Text |  |  |  | Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasionM Björkman, P Östling, V Härmä, J Virtanen, J-P Mpindi, J Rantala, T Mirtti, T Vesterinen, M Lundin, A Sankila, A Rannikko, E Kaivanto, P Kohonen, O Kallioniemi and M Nees Oncogene 2012 31: 3444-3456; advance online publication, November 28, 2011; 10.1038/onc.2011.512 Abstract | Full Text |  |  |  | EGFR signaling upregulates expression of microsomal prostaglandin E synthase-1 in cancer cells leading to enhanced tumorigenicityS Donnini, F Finetti, E Terzuoli, A Giachetti, M A Iñiguez, H Hanaka, M Fresno, O Rådmark and M Ziche Oncogene 2012 31: 3457-3466; advance online publication, November 14, 2011; 10.1038/onc.2011.503 Abstract | Full Text |  |  |  | NF-κB and STAT3 cooperatively induce IL6 in starved cancer cellsS Yoon, S U Woo, J H Kang, K Kim, H-J Shin, H-S Gwak, S Park and Y-J Chwae Oncogene 2012 31: 3467-3481; advance online publication, November 21, 2011; 10.1038/onc.2011.517 Abstract | Full Text |  | Corrigendum | Top |  | Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patientsX Li, K F Cheung, X Ma, L Tian, J Zhao, M Y Y Go, B Shen, A S L Cheng, J Ying, Q Tao, J J Y Sung, H-f Kung and J Yu Oncogene 2012 31: 3482; 10.1038/onc.2012.185 Full Text |  |  |  | | Advertisement |  | Call for papers! Submit your best work in cancer research, including mechanisms of cellular oncogene activation, structure and function of encoded proteins, DNA and RNA tumor viruses and all other aspects of oncogene structure and function.
Our online submission process is easy and can assist you in becoming part of this distinguished journal. Visit our Author page to learn about the benefits of publishing in the Journal and for guidelines on how to submit your paper. |
|  | | |  |  |  |  |  |  |  | Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.
Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com |  |  |  |  |  |
|  | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2012 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | |
|
|
No comments:
Post a Comment